BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 15995161)

  • 21. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
    Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
    J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary resection of soft-tissue sarcomas: yes and no.
    Frey E; Niggli F; Stauffer U; Plüss HJ
    Eur J Pediatr Surg; 1997 Aug; 7(4):227-9. PubMed ID: 9297518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft-tissue sarcomas in 39 dogs.
    Simon D; Ruslander DM; Rassnick KM; Wood CA; Frimberger AE; Cotter SM; King NW; Moore AS
    Vet Rec; 2007 Mar; 160(10):321-6. PubMed ID: 17351172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of pre-treatment biopsy for grading soft tissue sarcomas in dogs.
    Perry JA; Culp WT; Dailey DD; Eickhoff JC; Kamstock DA; Thamm DH
    Vet Comp Oncol; 2014 Jun; 12(2):106-13. PubMed ID: 22617002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid tumors.
    Richardson RC
    Vet Clin North Am Small Anim Pract; 1985 May; 15(3):557-67. PubMed ID: 3892869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of dogs with high-grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996-2004).
    Selting KA; Powers BE; Thompson LJ; Mittleman E; Tyler JW; Lafferty MH; Withrow SJ
    J Am Vet Med Assoc; 2005 Nov; 227(9):1442-8. PubMed ID: 16279389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incomplete histological margins following planned narrow excision of canine appendicular soft tissue sarcomas and mast cell tumors, using the residual tumor classification scheme.
    Haine DL; Pittaway R; Berlato D; Demetriou J
    Vet Surg; 2022 Oct; 51(7):1078-1086. PubMed ID: 35830150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of platinum content in biodegradable carboplatin-impregnated beads and retrospective assessment of tolerability for intralesional use of the beads in dogs following excision of subcutaneous sarcomas: 29 cases (2011-2014).
    Hess TA; Drinkhouse ME; Prey JD; Miller JM; Fettig AA; Carberry CA; Brenn SH; Bailey DB
    J Am Vet Med Assoc; 2018 Feb; 252(4):448-456. PubMed ID: 29393745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine soft tissue sarcoma managed in first opinion practice: outcome in 350 cases.
    Bray JP; Polton GA; McSporran KD; Bridges J; Whitbread TM
    Vet Surg; 2014 Oct; 43(7):774-82. PubMed ID: 24724565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgery.
    Baker-Gabb M; Hunt GB; France MP
    Aust Vet J; 2003 Dec; 81(12):732-8. PubMed ID: 15080482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical excision with five-centimeter margins for treatment of feline injection-site sarcomas: 91 cases (1998-2002).
    Phelps HA; Kuntz CA; Milner RJ; Powers BE; Bacon NJ
    J Am Vet Med Assoc; 2011 Jul; 239(1):97-106. PubMed ID: 21718202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of close but negative excision margin for treatment of soft-tissue sarcoma.
    Tang YW; Lai CS
    Ann Plast Surg; 2012 Dec; 69(6):633-6. PubMed ID: 23154334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intra-operative cisplatin for the treatment of canine extremity soft tissue sarcomas.
    Havlicek M; Straw RS; Langova V; Dernell WS
    Vet Comp Oncol; 2009 Jun; 7(2):122-9. PubMed ID: 19453366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum vascular endothelial growth factor in dogs with soft tissue sarcomas.
    de Queiroz GF; Dagli ML; Meira SA; Matera JM
    Vet Comp Oncol; 2013 Sep; 11(3):230-5. PubMed ID: 22372675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soft tissue sarcoma of the upper extremity.
    Murray PM
    Hand Clin; 2004 Aug; 20(3):325-33, vii. PubMed ID: 15275691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
    Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
    Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative radiotherapy for canine soft tissue sarcoma.
    Forrest LJ; Chun R; Adams WM; Cooley AJ; Vail DM
    J Vet Intern Med; 2000; 14(6):578-82. PubMed ID: 11110377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel imaging system permits real-time in vivo tumor bed assessment after resection of naturally occurring sarcomas in dogs.
    Eward WC; Mito JK; Eward CA; Carter JE; Ferrer JM; Kirsch DG; Brigman BE
    Clin Orthop Relat Res; 2013 Mar; 471(3):834-42. PubMed ID: 22972654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma.
    Wiley JL; Rook KA; Clifford CA; Gregor TP; Sorenmo KU
    Vet Comp Oncol; 2010 Sep; 8(3):221-33. PubMed ID: 20691029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation treatment for incompletely resected soft-tissue sarcomas in dogs.
    McKnight JA; Mauldin GN; McEntee MC; Meleo KA; Patnaik AK
    J Am Vet Med Assoc; 2000 Jul; 217(2):205-10. PubMed ID: 10909459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.